An international INVERSTROKE Study on risk Factors
On Friday the 18th of May the Lancet published a large international study that explores the availability and impact of different stroke treatments across more than 100 hospitals in 28 countries. Major improvements have been seen in the care of stroke patients in wealthy countries, the situation in low- and middle-income countries is not well understood. Professor Peter Langhorne of ICAMS has been national lead for the international INTERSTROKE study of risk factors for stroke and also led a sub-study exploring the association between patient recovery and their access to drug treatments and services.
This showed that evidence-based treatments, diagnostic investigations, and stroke units were less commonly available in low- and middle-income countries and that access to stroke units and the appropriate use of antiplatelet drugs were associated with improved recovery after stroke.
This large analysis was led by Professor Peter Langhorne of the School of Cardiovascular and Metabolic Health at the University of Glasgow and funded by Chest, Heart and Stroke, Scotland. The analysis was based on the landmark INTERSTROKE study that was coordinated by the Population Health Research Institute, McMaster University, Canada, and was supported by a range of Canadian and European funders.
This important result was reported at the European Stroke Organisation Congress in Gothenburg on Friday 18 May with simultaneous publication in the Lancet.
Professor Langhorne said; “these results indicate that if we can implement more widely the appropriate use of basic stroke treatments like multidisciplinary stroke units and aspirin then there is a real hope of improving the recovery of stroke patients around the world”.
First published: 23 May 2018